Synthesis, structure, and anticancer activity of gallium(III) complexes with asymmetric tridentate ligands: Growth inhibition and apoptosis induction of cisplatin-resistant neuroblastoma cells

Inorganic Chemistry

Volumn 45, Issue 16, 2006, Pages 6263-6268

  Shakya, Rajendra ^a   Peng, Fangyu ^b   Liu, Jianguo ^b   Heeg, Mary Jane ^a   Verani, Claudio N ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; GALLIUM; GROWTH INHIBITOR; LIGAND;

APOPTOSIS; ARTICLE; CELL CULTURE; CHEMISTRY; DRUG EFFECT; DRUG RESISTANCE; HUMAN; NEUROBLASTOMA; PHYSIOLOGY; SYNTHESIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELLS, CULTURED; CISPLATIN; DRUG RESISTANCE, NEOPLASM; GALLIUM; GROWTH INHIBITORS; HUMANS; LIGANDS; NEUROBLASTOMA;

EID: 33748285429     PISSN: 00201669     EISSN: None     Source Type: Journal    
DOI: 10.1021/ic060106g     Document Type: Article

References (29)

1. Olshan, A. F.; Bunin, G. R. Neuroblastoma; Brodeur, G. M., Sawada, T., Tsuchida, Y., Voute, P. A., Eds.; Elsevier: New York, 2000; p 33.
2. Niethammer D.; Handgretinger, R. Eur. J. Cancer 1995, 31A, 568.
3. Andrews, P. A. Anticancer Drug Resistance; Goldstein, L. J., Ozols, R. F. Eds.; Kluwer Academic: Boston, 1994; p 217.
4. Bernstein, M. L.; Reaman, G. H.; Hirschfeld, S. Hematol. Oncol. Clin. North Am. 2001, 15, 631.
5. Jain, R. K. Clin. Cancer Res. 1999, 5, 1605.
6. Wang, J.; Maurer, L. Curr. Top. Med. Chem. 2005, 5, 1053.
7. Dobrov, A.; Arion, V. B.; Kandler, N.; Ginzinger, W.; Jakupec, M. A.; Rufinska, A.; von Keyserlingk, N. G.; Galanski, M.; Kowol, C.; Keppler, B. K Inorg. Chem. 2006, 45, 1945.
8. Bernstein, L. R. Metallotherapeutic Drugs and Metal-Based Diagnostic Agents; Gielen, M., Tiekink, E. R. T., Eds.; Wiley: Weinheim, Germany, 2005, 259.
9. Bernstein, L. R. Pharmacol. Rev. 1998, 50, 665.
10. Harpstrite, S. E.; Beatty, A. A.; Collins, S. D.; Oksman, A.; Goldberg, D. E.; Sharma, V. Inorg. Chem. 2003, 42, 2294.
11. (a) Fulton, D. A.; Elemento, E. M.; Aime, S.; Chaabane, L.; Botta, M.; Parker, D. Chem. Commun. 2006, 1064.
12. (b) Storr, T.; Sugai, Y.; Barta, C. A.; Mikata, Y.; Adam, M. J.; Yano, S.; Orvig, C. Inorg. Chem. 2005, 44, 2698.
13. (c) Caravan, P.; Ellison, J. J.; McMurry, T. J.; Lauffer, R. B. Chem. Rev. 1999, 99, 2293.
14. Imbert, C.; Hratchian, H. P.; Lanznaster, M.; Heeg, M. J.; Hryhorczuk, L. M.; McGarvey, B. R.; Schlegel, H. B.; Verani, C. N. Inorg. Chem. 2005, 44, 7414 and references therein;
15. Shakya, R.; Imbert, C.; Hratchian, H. P.; Lanznaster, M.; Heeg, M. J.; McGarvey, B. R.; Allard, M.; Schlegel, H. B.; Verani, C. N. Dalton Trans. 2006, 2517.
16. APEX II collection and processing programs are distributed by Bruker AXS Inc., Madison WI.
17. Sheldrick, G. SHELX-97; University of Göttingen: Göttingen, Germany, 1997.
18. Mosmann, T. J. Immunol. Methods 1983, 65, 55.
19. Vermes I.; Haanen, C.; Steffens-Nakken, H.; Reutelingsperger, C. J. Immunol. Methods 1995, 184, 39.
20. Elstein, K. H.; Zucker, R. M. Exp. Cell Res. 1994, 211, 322.
21. phen) groups. Subscripts 1 and 2 designate the first and the second ligands, respectively.
22. (a) Darensbourg, D. J.; Billodeaux, D. R. C. R. Chim. 2004, 07, 755.
23. (b) Beckmann, U.; Bill, E.; Weyhermüller, T.; Wieghardt, K. Eur. J. Inorg. Chem. 2003, 09, 1768.
24. (c) Van Aelstyn, M. A.; Keizer, T. S.; Klopotek, D. L.; Liu, S.; Munoz-Hernandez, M.-A.; Wei, P.; Atwood, D. A. Organometallics 2000, 19, 1796.
25. (d) Brown, M. A.; El-Hadad, A. A.; McGarvey, B. R.; Sung, R. C. W.; Trikha, A. K.; Tuck, D. G. Inorg. Chim. Acta 2000, 300, 613.
26. (e) Camacho-Camacho, C.; Merino, G.; Martínez-Martínez, F. J.; Nöth, H.; Contreras, R. Eur. J. Inorg. Chem. 1999, 06, 1021.
27. (f) Wong, E.; Caravan, P.; Liu, S.; Rettig, S. J.; Orvig, C. Inorg. Chem. 1996, 35, 715.
28. (g) Wong, E.; Liu, S.; Rettig, S.; Orvig, C. Inorg. Chem. 1995, 34, 3057.
29. Jamieson, E. R.; Lippard, S. J. Chem. Rev. 1999, 99, 2467.